Upload Avatar (500 x 500)
Li Jinlong
Laboratory Medicine and Biotechnology
Southern Medical University
Guangdong
Language: Chinese, English
Tumor
Drug Resistance
Cancer
Chemotherapy
Oncology
Immunotherapy
Immune Response
Cancer Cells
Treatment
Research
Areas of Focus
- Tumor Drug Resistance
- Tumor Immunity
Academic Background & Achievements
- 1993.9-1996.7 Clinical Medicine: Shandong Linyi Medical College
- 2000.9-2003.7 Pathology and Pathophysiology, Master's: Zhengzhou University
- 2003.9-2006.7 Oncology, Doctorate: Sun Yat-sen University
Publications
- Phenotypic transition of tumor cells between epithelial- and mesenchymal-like state during adaptation to acidosis., Zhang Y, Xu L, Wang P, Jian H, Shi X, Jia M, Mo L, Hu Z, Li H, Li J., 2019
- Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells., Mo L, Zhang X, Shi X, Wei L, Zheng D, Li H, Gao J, Li J, Hu Z., 2018
- Pre-RC Protein MCM7 depletion promotes mitotic exit by Inhibiting CDK1 activity., Zheng D, Ye S, Wang X, Zhang Y, Yan D, Cai X, Gao W, Shan H, Gao Y, Chen J, Hu Z, Li H, Li J., 2017
- Adenovirus-Mediated Angiotensin II Type 2 Receptor Overexpression Inhibits Tumor Growth of Prostate Cancer In Vivo., Li J, Luo J, Gu D, Jie F, Pei N, Li A, Chen X, Zhang Y, Du H, Chen B, Gu W, Sumners C, Li H., 2016
- Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells., Chen S, Chen X, Xie G, He Y, Yan D, Zheng D, Li S, Fu X, Li Y, Pang X, Hu Z, Li H, Tan W, Li J., 2016
